These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 10074215)

  • 1. [Valoration of the epidermal growth factor receptor (EGFR) in benign breast disease and its relation with expression in malignant tumors classified by hormonal dependence].
    Allende MT; Raigoso PF; Alvarez A; Llana B; Sánchez A; Martínez MI; Miralles MT; Roiz C
    Rev Esp Med Nucl; 1999; 18(1):32-6. PubMed ID: 10074215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cytosolic pS2 levels and cellular proliferation in ER-positive and PgR-positive infiltrating ductal carcinomas of the breast].
    Sánchez Salmón A; Argibay S; Arias JI; Ruibal A
    Rev Esp Med Nucl; 2005; 24(3):185-90. PubMed ID: 15847785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical-biological meaning of progesterone receptor status in 118 estrogen receptor positive infiltrating ductal carcinomas of the breast in post-menopausal women].
    Ruibal A; Schneider J; Arias J; del Río MC; Núnez MJ; Tejerina A
    Rev Esp Med Nucl; 2000 Jun; 19(3):244-6. PubMed ID: 11062090
    [No Abstract]   [Full Text] [Related]  

  • 4. [Expression of epidermal growth factor receptor (EGFR) in hormone-independent breast cancers].
    Ruibal A; Garrido-Pumar M; Arias JI
    Rev Esp Med Nucl; 2006; 25(1):15-9. PubMed ID: 16540006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical-biological characteristics of infiltrating ductal carcinomas of the breast with estrogen receptor concentrations >300 fmol/mg protein].
    Resino C; Arias JI; Del Río MC; Sánchez Hermosa C; Ruibal A
    Rev Esp Med Nucl; 2001 Oct; 20(6):503-5. PubMed ID: 11578586
    [No Abstract]   [Full Text] [Related]  

  • 6. [Study of the cytosolic concentrations of the tissue poly-peptide specific (TPS) antigen in infiltrating ductal carcinomas of the breast. Positive relationship with hormone dependency and negative with cellular proliferation].
    Ruibal A; Arias JI; Resino C; Lapeña G; Schneider J; Tejerina A
    Rev Esp Med Nucl; 2001 Aug; 20(5):365-8. PubMed ID: 11470070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MR imaging features of invasive breast cancer correlated with hormonal receptors: does progesterone receptor matter?
    Chen JH; Nalcioglu O; Su MY
    Ann Oncol; 2008 May; 19(5):1024-6. PubMed ID: 18375524
    [No Abstract]   [Full Text] [Related]  

  • 8. DAX-1 expression in human breast cancer: comparison with estrogen receptors ER-alpha, ER-beta and androgen receptor status.
    Conde I; Alfaro JM; Fraile B; Ruíz A; Paniagua R; Arenas MI
    Breast Cancer Res; 2004; 6(3):R140-8. PubMed ID: 15084237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlations of survivin expression with clinicomorphological parameters and hormonal receptor status in breast ductal carcinoma.
    Adamkov M; Kajo K; Vybohova D; Krajcovic J; Stuller F; Rajcani J
    Neoplasma; 2012; 59(1):30-7. PubMed ID: 22103896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of estrogen, progesterone, and epidermal growth factor receptors in normal, benign, and malignant human breast tissues using dual staining immunohistochemistry.
    van Agthoven T; Timmermans M; Foekens JA; Dorssers LC; Henzen-Logmans SC
    Am J Pathol; 1994 Jun; 144(6):1238-46. PubMed ID: 7515559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hormone-dependent, diploid, infiltrating ductal breast carcinomas less than 2 cm in size: influence of an exclusive and moderate cellular proliferation on the clinicobiological features and recurrences of these malignant tumors].
    Ruibal A; Arias JI
    Rev Esp Med Nucl; 2002; 21(6):437-8. PubMed ID: 12425893
    [No Abstract]   [Full Text] [Related]  

  • 12. Pigmented Cutaneous Metastasis of Breast Carcinoma Mimicking a Melanoma.
    Ubillos N; Vola M; Mazzei ME; Magliano J
    Actas Dermosifiliogr; 2016 Oct; 107(8):699-701. PubMed ID: 27206606
    [No Abstract]   [Full Text] [Related]  

  • 13. CA 15-3 serum levels in patients with ductal breast carcinoma: relationship with clinicopathological parameters and tumor markers.
    González-Sistal A; Arias JI; Ruibal A
    Int J Biol Markers; 2012; 27(1):47-52. PubMed ID: 21928245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapeutic targeting in breast cancer].
    Penault-Llorca F
    Ann Pathol; 2009 Nov; 29 Spec No 1():S71-3. PubMed ID: 19887259
    [No Abstract]   [Full Text] [Related]  

  • 15. Expression of prolactin receptors in normal, benign, and malignant breast tissue: an immunohistological study.
    Gill S; Peston D; Vonderhaar BK; Shousha S
    J Clin Pathol; 2001 Dec; 54(12):956-60. PubMed ID: 11729217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HER2 as a prognostic factor in breast cancer.
    Ménard S; Fortis S; Castiglioni F; Agresti R; Balsari A
    Oncology; 2001; 61 Suppl 2():67-72. PubMed ID: 11694790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of oestrogen receptor-beta in invasive breast tumours].
    Péter I; Számel I; Péley G
    Magy Onkol; 2004; 48(1):63-9. PubMed ID: 15105898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Zosteriform eruption resistant to acyclovir].
    Orgaz-Molina J; Cotugno M; Aneiros-Fernández J; Arias-Santiago S
    Med Clin (Barc); 2013 Aug; 141(4):188. PubMed ID: 23597955
    [No Abstract]   [Full Text] [Related]  

  • 19. Cytosolic tissue-type plasminogen activator (t-PA) levels in ductal infiltrating carcinomas of the breast classified according to different clinical and biological parameters.
    García Muñiz JL; Alvarez A; Fernández Llana B; Fernández Raigoso P; Allende MT; Ruibal A
    Int J Biol Markers; 1995; 10(2):119-21. PubMed ID: 7561238
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunohistochemical localization of metallothionein in human breast cancer in comparison with cathepsin D, stromelysin-1, CD44, extracellular matrix components, P53, Rb, C-erbB-2, EGFR, steroid receptor content and proliferation.
    Ioachim E; Kamina S; Demou A; Kontostolis M; Lolis D; Agnantis NJ
    Anticancer Res; 1999; 19(3A):2133-9. PubMed ID: 10470161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.